Background: NOD proteins are part of innate immunity mechanisms. They play a role in epithelial barrier functions and inflammatory responses to bacteria. Single nucleotide polymorphisms (SNPs) in the NOD1 gene have proven to be associated with inflammatory bowel disease (IBD) and asthma. Objective: To investigate SNPs in the NOD1 gene in relation to aggressive periodontitis (AgP), a multifactorial, inflammatory disease of the supporting tissues of the teeth. Materials and Methods: Five SNPs in the NOD1 gene (4 intronic and 1 exonic) were tested for association in a total of 415 AgP patients and 874 controls both of Northern European ancestry. Results: The frequencies of the rare SNP alleles ranged between 21% and 26% among cases, and 20-27% among controls, and were not statistically different between cases and controls. Two SNPs were in strong linkage disequilibrium (r 2 ¼ 0.97 in cases and 0.94 in controls). The overall haplotype distributions did not differ between cases and controls. We observed 8 haplotypes with a frequency of !1% among cases and/or controls, but none of these haplotype frequencies differed significantly among cases and controls. Logistic regression analyses with adjustment for gender and smoking status did not reveal significant associations with AgP for any of the 5 SNPs. This study had a power of !95% to detect associations with variants carrying relative risks of !1.5 for heterozygote carriers and !2.25 for homozygote carriers. Conclusions: Although SNPs in the NOD1 gene have been strongly associated with cases of IBD, the current study failed to show an association of NOD1 SNPs with AgP.
INTRODUCTION
Periodontitis is a chronic inflammatory disease of the supporting tissues of the teeth. 1 The chronic inflammatory condition with concomitant breakdown of tooth support is initiated by infection of periodontal pockets with a number of Gram-negative, often anaerobic, bacteria, including Porphyromonas gingivalis, Tannerella forsythensis, Prevotella intermedia and Aggregatibacter actinomycetemcomitans. Disease modifying genes may determine the type and intensity of the host response and, therefore, susceptibility for periodontitis. 2 Two common forms of periodontitis are recognized. Chronic periodontitis is the most prevalent form and considered to have a slow on-going process, in general with an age of onset 435 years. The prevalence of chronic periodontitis is estimated at 10% of the adult population. The rapidly progressing and severe form of periodontitis, often occurring in post-adolescent individuals (535 years), is classified as aggressive periodontitis (AgP). This aggressive form of periodontitis is estimated to occur at 0.1-1% in populations of European ancestry. 3 Although periodontitis is initiated by infection with bacteria in dental biofilm, it is a multifactorial disease displaying clear genetic traits. There is accumulating evidence that genetic factors play a more dominant role in the susceptibility for aggressive periodontitis than for chronic adult periodontitis. 2 Genes encoding for molecules participating in innate mucosal immunity are likely targets for candidate gene approaches aiming at elucidating the genetic basis of periodontitis. 4 In the current study, we focus on single nucleotide polymorphisms (SNPs) in NOD1 (caspase recruitment domain family, member 4) encoding for NOD1 (nucleotide binding oligomerization domain protein 1) which is involved in epithelial barrier function and inflammatory responses to bacteria and bacterial components. The NOD1 gene is on chromosome 7p14, in a region that has been genetically linked to asthma and inflammatory bowel disease (IBD). 5, 6 Genetic variants in NOD1 were found to be a risk factor for IBD in a British population, 6 but controversy exists; this association could not be replicated in German, Scottish and Swedish study samples. 7, 8 Nevertheless, NOD1 is an pertinent candidate gene for periodontitis because the disease is initiated by bacteria 9 and, like various other inflammatory diseases including Crohn disease, ulcerative colitis, atopic eczema, asthma, sarcoidosis and psoriasis, AgP might share common susceptibility genes. 10 In the present study, we investigated five SNPs in the NOD1 gene as possible susceptibility factors for AgP in subjects of Northern European ancestry. These were the five key SNPs that had functional consequences and/or were associated with IBD as published by McGovern et al. 6 
SUBJECTS AND METHODS

Study population
A total of 415 patients with aggressive periodontitis (AgP) were recruited through the European Periodontal Genetics (EPG) consortium. From these, 261 patients were of German origin and 154 patients were of Dutch origin. In addition, 874 German and Dutch controls (GC and DC, respectively) from Northern European ancestry were included. For the controls, aspects of medical history, health status and smoking habits (current and former smoker, non-smoker or smoking status unknown) were recorded and evaluated with a questionnaire. Questions comprised gum-diseases (bleeding and swelling of the gums, tooth mobility, movement of teeth, extraction of teeth because of periodontal disease, family history of any gum-diseases) and the general health status (e.g. coronary heart disease, metabolic diseases [e.g. diabetes], gastrointestinal diseases, infectious diseases). Subjects with a history of diabetes, hepatitis or HIV infection were excluded from the study. The GC group consisted of 501 subjects and was recruited through anonymous blood donors of European Caucasian descent (POPGEN biobank). 11 They were randomly identified through resident's registration offices. All GC participants gave written informed consent prior to enrolment, and the Ethics Committee of the University Hospital Schleswig-Holstein, Campus Kiel, approved the study. The DC controls (n ¼ 373) were anonymous blood donors recruited through the Sanquin Bloodbank (Amsterdam, The Netherlands). All DC gave written informed consent prior to enrolment and the Review Board of the Sanquin Bloodbank approved the study.
Inclusion criteria for the patients were as follows: Northern European ancestry, age at diagnosis 35 years, a set of full-mouth dental radiographs available for periodontal bone scoring and !2 teeth with !50% periodontal bone loss. Aspects of the medical history and smoking habits were recorded and evaluated. The individual medical ethical committees of the respective centers participating in the EPG consortium approved the study. Data protection of private information such as the subject's name and address was ensured by using anonymized identifiers. 11 All patients and blood donors donated 30 ml whole blood in an EDTA-containing vacuum tube for DNA extraction. All blood samples were subsequently frozen and stored at -80 C.
Clinical assessments
For all patients with AgP, the total number of teeth was recorded. Radiographs of all teeth were evaluated by a periodontist or calibrated examiner to determine the approximate bone loss, using the cemento-enamel junction of the tooth and the tooth apex as reference points. Bone loss at the worst approximate site per tooth was recorded, expressed as a percentage of the total root length. In this way, for each patient, the number of teeth with bone loss 450% was tabulated. We divided patients with AgP in three groups based on the number of affected teeth (Table 1) .
DNA isolation and genotyping
Genomic DNA was prepared from defrosted blood samples with the Invisorb Blood Giga Kit (Invitec; Berlin, Germany). All DNA samples were quality checked on an agarose gel. Mutations were assayed with TaqMan Õ (Applied Biosystems [ABI]; Foster City, CA, USA) on an automated platform. 12 In brief, genomic DNA was arrayed and dried on 96-well and 384-well plates. TaqMan PCR was set up with Genesis pipetting robots (Tecan; Männedorf, Switzerland). Samples were amplified with ABI 9700 PCR machines and fluorescence was measured with ABI 7700 and ABI 7900 fluorometers. TaqMan Õ consists of a single-tube PCR assay, which exploits the 5 0 -exonuclease activity of DNA polymerase. 13 The assay includes two locusspecific PCR primers that flank the SNP of interest (F [forward] and R [reverse]) and two allele-specific oligonucleotide TaqMan Õ probes (VIC and FAM probe). The SNPs investigated and the primers that were used are listed in Tables 2 and 3 , respectively. For all ten assays, the same PCR-protocol was used: (i) activation of the Ampli Taq Gold Õ -95 C, 10 min, 1 cycle; (ii) denaturation step -95 C, 15 s, 45 cycles; (iii) annealing, elongation and nucleolytic cleavage of hybridized probes -60 C, 1 min, 45 cycles; and (iv) storage at 4 C. For the end-point measurement, we used the ABIPrism Õ 7900 HT Sequence Detection System. Allele calling was done manually to insure high quality data. All process data were logged into, and administered by, a database-driven laboratory information management system (LIMS/3). 14 
Statistical analysis
All SNPs were required to have a call rate of at least 95% prior to inclusion in the analysis. Deviations from Hardy-Weinberg equilibrium were tested in the control group by using an exact test 15 and a type 1 error level of 0.05. The association with AgP was examined for each marker by using Haploview 4.016 and the Genomizer Engine, 14 an in-house tool that performs contingency table tests for genotype and allele frequencies and also provides empirical significances for P-values as well as confidence intervals for odds ratios (OR) through randomization and bootstrapping. The ratios of gender and of smoking status varied strongly between cases and controls. A summary of the characteristics of patients with AgP (cases) and controls is presented in Table 1 . Logistic regression was used to test for phenotypic association while adjusting for effects of gender and smoking habits to avoid any confounding by these factors. The patient recruitment scheme was designed to ensure that cases were more likely to be genetically susceptible to AgP due to the early onset (535 years). In contrast, controls being older on average than cases, were not having periodontitis, therefore making a genetic susceptibility less likely. As a consequence, age was not included as co-variate in the regression analysis, since it was purposely part of the recruitment scheme. Each SNP was considered under a dominant, multiplicative, and recessive effect model. Likelihoodratio as well as Wald tests were applied. P-values50.01 were considered significant. A subgroup analysis, which considered only cases in groups 2 and 3 (see Table 1 ), and the inclusion of an interaction term genotypingsmoking status in the model was also performed. Estimation of linkage disequilibrium (LD) between markers was carried out using Haploview 4.0beta15 (Day Lab, Broad Institute, Cambridge, MA, USA) and Haplohack 3.2.0.
14 Haplotype frequencies were estimated and haplotype tests for phenotypic association were carried out by using FamHap, release 16. 17 FamHap implements an Expectation-Maximization (EM) algorithm for frequency estimation and likelihood-ratio tests as well simulation procedures to test for haplotype association. Frequency confidence intervals were calculated by using non-parametric bootstrapping with 10.000 replications, implemented in Perl scripts.
For assessing the statistical power of our results to reveal potential genetic associations, we considered a multiplicative model for each SNP. Disease prevalence was assumed to equal 1%, while the locus allele frequency was assumed to equal 0.25, roughly corresponding to the lower limit of the observed marker allele frequencies in the control group. Causative variants were assumed to be either genotyped or perfectly correlated with a marker genotyped in this study. Applying conservative Bonferroni correction, the significance level was set to a ¼ 0.01. Calculations were carried out using the Genetic Power Calculator. 18 Table 1 presents the background characteristics for the 415 Northern European AgP patients and 874 Northern European controls. The significantly higher proportion of females than males was caused by the fact that more females than males presented for diagnosis and treatment. In addition, male patients more often chose not to participate in the study because they hesitated to donate a blood sample, both in The Netherlands and in Germany. In addition in Table 1 , we present the mean number of affected teeth and proportions of patient within the three severity classes. The total number of controls was 874, consisting of 501 German and 373 Dutch individuals. The ratios of German to Dutch cases and of German to Dutch controls were almost equal. For the controls, the male-to-female ratio was 50 : 50. The mean age was 48.4 years (range, 18-77 years). In the control cohort, 406 (47%) current and former smokers participated in the study, 458 (52%) individuals were non-smokers and 10 had an unknown smoking status.
RESULTS
Study population and clinical findings
Prevalence of NOD1 genotypes and alleles
Five polymorphisms in the NOD1 gene (Table 2) were genotyped. All five assays had a call rate 495% and showed no significant deviation from the HardyWeinberg equilibrium in the control panel ( Table 4) . The rare allele frequencies of the five SNPs in the control population varied between 20% and 27%; frequencies of the rare allele in the patient population varied between 21% and 26%. For the allele distribution (i.e. under a multiplicative effect model), none of the SNPs showed a statistically significant difference in the frequencies between cases and controls. None of the SNPs showed statistically significant differences in the genotype frequencies between cases and controls (genotypic P-values 40.1). Similarly, carrier-ship of the rare allele (i.e. dominant effect model) was not different between cases and controls (P-values 40.05; Table 4 ).
Linkage disequilibrium plots and haplotype analysis
Linkage disequilibrium was assessed by the squared correlation coefficient (r 2 ). The LD structures of cases and controls were comparable (Fig. 1A,B) . The SNPs 4 and 5 were in strong LD (r 2 ¼ 0.97 in cases and 0.94 in controls). SNPs 3-4 and 3-5 were moderately associated (r 2 values ranged from 0.66 to 0.76). The overall haplotype distributions did not differ between cases and controls (global P ¼ 0.08). For the five SNPs, we observed eight haplotypes with a frequency of !1% among cases and/or controls. Haplotype 12211 had the highest frequency in this study population (45% for both cases and controls). None of these haplotype frequencies differed significantly among cases and controls; frequency 95% confidence intervals overlapped for all haplotypes between cases and controls (Table 5) .
Logistic regression analysis
All SNPs were tested for association under a dominant, a multiplicative, and a recessive model by using the likelihood-ratio test (LRT) and the Wald test with adjustment for the known risk factors smoking and gender, both separately and combined. Results for both tests were very similar; therefore, we report only LRT Pvalues (Table 6 ). None of the tested SNPs showed any nominally significant association (P-value 50.05) for any of the models. Neither a sub-group analysis, which considered only cases in severity categories 2 and 3 (see Table 1 ), nor the inclusion of an interaction term genotyping-smoking status in the model altered these results (data not shown).
Power calculation
Our study had 95% power to detect genotyped susceptibility alleles with frequencies !0.20 at a ¼ 0.01 (five markers tested) using a multiplicative risk model with estimated relative risks for AgP of 1.5 and 2.25 for heterozygous and homozygous carriers, respectively. If the relative risks for AgP related to a NOD1 susceptibility allele would be 1.2 and 1.44 for heterozygous and homozygous carriers, respectively, the Given is the nominal P adjusted -value, the corresponding OR, and the genetic effect model from which the smallest P-value for each marker could be obtained. OR, odds ratio; CI, 95% confidence interval. Table 2 .
power of the current study would drop to 22%; with these latter relative risks, at least 1882 cases and an equal number of controls should have been included in the study to reach 90% power.
DISCUSSION
The family of NOD proteins includes Apaf-1, Ced-4, NOD1 and NOD2; these are intracellular regulatory proteins with a central nucleotide-binding oligomerization domain (NOD) and N-terminal caspase recruitment domains (CARD) and they are involved in programmed cell death and innate immune responses. The NOD proteins have C-terminal multiple leucine-rich regions (LRRs) that are homologous to LRR in Toll-like receptors. The LRRs are able to bind diaminopimelic acid (DAP) in bacterial peptidoglycans (PGN) 19 and function as pattern recognition receptors (PRRs). Oral epithelial cells constitutively express NOD proteins and stimulation with synthetic ligands for the receptors induces -defensin 2, 20 but not inflammatory cytokines. 21 As periodontitis is caused by the effects of oral bacteria, polymorphisms affecting the function of NOD1 can constitute a susceptibility factor for this condition.
We examined five NOD1 SNPs and found that none differed significantly in the allelic or genotype frequencies between patients with AgP and controls. Haplotype analyses also showed no significant differences between the diseased and healthy groups. We considered that the intronic SNP ND 1 þ 32656 could be of particular importance, since this SNP has been found to be strongly associated with IBD and Crohn disease, especially the early onset forms, 6 and since this SNP seems functional; it may alter the splicing of NOD1 by affecting the binding of an unknown nuclear factor. 5 Our findings are in contrast to the association of NOD1 polymorphisms with the inflammatory diseases IBD and asthma, as found in a large British cohort, 6 and in Australian and UK nuclear families. 5 In fact, a lack of consensus exists on the association of NOD1 SNPs and IBD: this association could not be replicated in German, Scottish and Swedish study samples. 7, 8 The discrepant findings regarding NOD1 and IBD may reflect subtle genetic differences between the British population and the other ethnic populations. 22 This phenomenon may also have affected the current results in AgP: other ethnicities throughout the world may still show a positive association of NOD1 SNPs with AgP, in particular the ND 1 þ 32656 SNP. Otherwise, the association between IBD and periodontitis is also still controversial. 23 Studies on identification of genetic factors related to susceptibility of periodontitis have not shown consistent results, even among subjects of the same ethnic background. 2, 4 Genetic polymorphisms in genes encoding proteins such as interleukin (IL)-1, FcgR, IL-6 and NOD2 have been studied in relation to periodontitis. The results point towards the existence of genetic risk factors for periodontitis, but the study populations have been small and yielded insufficient power, and falsepositive results can, therefore, not be excluded. 2, 4 As in other complex diseases, genetic studies in periodontitis are complicated because multiple modifying genes are thought to play a role, perhaps as much as 20. 2 The current study did have enough power (95%) to conclude that the five selected NOD1 gene polymorphisms are not associated with AgP, if the relative risk of these SNPS is at least above 1.5 and 2.25 for heterozygous and homozygous carriers, respectively. However, if there would be more than 20 genes involved in the disease, each with a small overall risk (for example, 1.2 and 1.44 for heterozygous and homozygous carriers, respectively), the power of the current and other studies on periodontitis would drop considerably, perhaps to 20%. Another challenge is to take into account other established risk factors as co-variates. For periodontitis, at least smoking should be included in multivariate statistical analyses. 24 At present, logistic regression models were included, but no statistically significant associations were found.
CONCLUSIONS
In the current case-control study, five SNPs in the NOD1 gene were not associated with AgP in a sizeable sample of German-Dutch subjects. This means that it is unlikely that polymorphisms in the NOD1 gene contribute to the susceptibility for AgP in these countries.
